Biocept, Inc.
(NASDAQ : BIOC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
DVADaVita, Inc. -6.86%65.483.1%$139.24m
GHGuardant Health, Inc. -7.11%60.490.0%$81.66m
AMEDAmedisys, Inc. -1.27%176.6611.5%$62.72m
CHEChemed Corp. -2.72%416.0710.0%$61.99m
LHCGLHC Group, Inc. -4.53%122.742.9%$54.85m
NVTAInvitae Corp. -0.24%12.622.5%$48.69m
NTRANatera, Inc. -1.80%27.211.3%$32.62m
SDCSmileDirectClub, Inc. -4.20%3.880.0%$27.43m
ACHCAcadia Healthcare Co., Inc. -12.16%15.5327.2%$26.70m
NEONeoGenomics, Inc. -10.43%24.216.0%$26.66m
ENSGThe Ensign Group, Inc. 2.18%32.825.8%$21.04m
ONEM1Life Healthcare, Inc. 3.74%18.590.0%$20.58m
FMSFresenius Medical Care AG & Co. KGaA -0.09%32.300.1%$18.79m
MDMEDNAX, Inc. -6.99%9.7211.2%$15.84m
ADUSAddus HomeCare Corp. 3.83%71.531.0%$14.99m

Company Profile

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.